BD Board Declares Dividend
Date
7/23/2024 4:38:12 PM
(MENAFN- PR Newswire)
FRANKLIN LAKES, N.J., July 23, 2024 /PRNewswire/ -- The Board of Directors of
BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on September 30, 2024 to holders of record on September 9, 2024. The indicated annual dividend rate is $3.80 per share.
About BD
BD is one of the largest global medical Technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd or connect with us on LinkedIn at , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .
| Contacts: |
|
|
|
| Media: |
Investors: |
| Troy Kirkpatrick |
Adam Reiffe |
| VP, Public Relations |
Sr. Director, Investor Relations |
| 858.617.2361 |
201.847.6927 |
| [email protected] |
[email protected] |
SOURCE BD (Becton, Dickinson and Company)
MENAFN23072024003732001241ID1108473307
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.